CAPE TOWN (Reuters) – South Africa’s lead investigator for the Johnson & Johnson trial, Glenda Gray, said on Thursday the country’s regulator was processing an application for the vaccine to be granted emergency authorisation against COVID-19.
Addressing a webinar on vaccines, Gray said they were in discussions with regulatory authorities to roll out the single-dose vaccine to health workers, after the government earlier this week halted the roll out of the AstraZeneca vaccine over efficacy concerns.
(Reporting by Wendell Roelf and Promit Mukherjee)
